It is important to find specific and easily detectable diagnostic markers in acute stage of spinal cord injury for guiding treatment and estimating prognosis. Although, microRNAs are attractive biomarkers, there is still no uniform standard for clinical evaluation of spinal cord injury based on “free circulation” miRNA spectrum. The reason may be that miRNA analysis from biological fluids is influenced by many pre-analysis variables. Exosome miRNAs are widely distributed in body fluids and have many advantages comparing with free miRNAs. The specific miRNAs in the central nervous system can be transported to the peripheral circulation and concentrated in exosomes. Therefore, we hypothesized that there might be some physiological changes associated with spinal cord injury in serum exosomal miRNAs. Using next-generation sequencing, miRNA profiles in serum exosomes of sham and acute spinal cord injury rats were analyzed, and integrative bioinformatics were used to analyze the function and regulation of putative target genes. The results showed that acute spinal cord injury can lead to changes in miRNA expression in the circulating exosomes. The changed miRNAs and their associated pathways may explain the pathology of acute spinal cord injury. More importantly, we determined serum exosomal miR-125b-5p, miR-152-3p, and miR-130a-3p are specific and easily detectable diagnostic markers in acute spinal cord injury. More interestingly, we also found some valuable known and novel miRNAs. Further bioinformatics analysis and functional research will be of great help to make clear their role in the pathological process of spinal cord injury and judging whether they can be used as diagnostic markers.
Impact statement
This research hypothesized that there might be some physiological changes associated with SCI in serum exosomal miRNAs. Using next-generation sequencing, miRNA profiles in serum exosomes of sham and acute SCI rats were analyzed, and integrative bioinformatics were used to analyze the function and regulation of putative target genes. The results showed that acute SCI can lead to changes in miRNA expression in the circulating exosomes. The changed miRNAs and their associated pathways may explain the pathology of acute SCI. More importantly, we determined serum exosomal miR-125b-5p, miR-152-3p, and miR-130a-3p are specific and easily detectable diagnostic markers in acute SCI.
FriedliLRosenzweigESBarraudQSchubertMDominiciNAwaiLNielsonJLMusienkoPNout-LomasYZhongHZdunowskiSRoyRRStrandSCvan den BrandRHavtonLABeattieMSBresnahanJCBezardEBlochJEdgertonVRFergusonARCurtATuszynskiMHCourtineG.Pronounced species divergence in corticospinal tract reorganization and functional recovery after lateralized spinal cord injury favors primates. Sci Transl Med2015;
7:302ra134
2.
FurlanJCFehlingsMG.Role of screening tests for deep venous thrombosis in asymptomatic adults with acute spinal cord injury: an evidence-based analysis. Spine2007;
32:1908–16
3.
FehlingsMGTatorCH.An evidence-based review of decompressive surgery in acute spinal cord injury: rationale, indications, and timing based on experimental and clinical studies. J Neurosurg1999;
91:1–11
KwonBKStreijgerFFallahNNoonanVKBelangerLMRitchieLPaquetteSJAilonTBoydMCStreetJFisherCGDvorakMF.Cerebrospinal fluid biomarkers to stratify injury severity and predict outcome in human traumatic spinal cord injury. J Neurotrauma2017;
34:567–80
6.
BadhiwalaJHAhujaCSFehlingsMG.Time is spine: a review of translational advances in spinal cord injury. J Neurosurg Spine2018;
30:1–18
7.
TalbottJFWhetstoneWDReaddyWJFergusonARBresnahanJCSaigalRHawrylukGWBeattieMSMabrayMCPanJZManleyGTDhallSS.The brain and spinal injury center score: a novel, simple, and reproducible method for assessing the severity of acute cervical spinal cord injury with axial T2-weighted MRI findings. J Neurosurg Spine2015;
23:495–504
8.
WilsonJRTetreaultLAKwonBKArnoldPMMrozTEShaffreyCHarropJSChapmanJRCashaSSkellyACHolmerHKBrodtEDFehlingsMG.Timing of decompression in patients with acute spinal cord injury: a systematic review. Global Spine J2017;
7:95S–115S
9.
FagerlundMK.Acute neuroradiology: methods, indications and timing. Ann Med1995;
27:657–62
10.
Martinez-UserosJGarcia-FoncillasJ.Obesity and colorectal cancer: molecular features of adipose tissue. J Transl Med2016;
14:21
11.
AdegunsoyeABalachandranJ.Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea. Mediators Inflamm2015;
2015:510105
12.
WinnerkvistAAndersonREHanssonLORosengrenLEstreraAEHuynhTTPoratEESafiHJ.Multilevel somatosensory evoked potentials and cerebrospinal proteins: indicators of spinal cord injury in thoracoabdominal aortic aneurysm surgery. Eur J Cardiothorac Surg2007;
31:637–42
13.
HombachSKretzM.Non-coding RNAs: classification, biology and functioning. Adv Exp Med Biol2016;
937:3–17
14.
MaLBajicVBZhangZ.On the classification of long non-coding RNAs. RNA Biol2013;
10:925–33
15.
HachisukaSKameiNUjigoSMiyakiSYasunagaYOchiM.Circulating microRNAs as biomarkers for evaluating the severity of acute spinal cord injury. Spinal Cord2014;
52:596–600
16.
TigchelaarSStreijgerFSinhaSFlibotteSManouchehriNSoKShorttKOkonERizzutoMAMalenicaICourtright-LimAEisenAKeuren-JensenKVNislowCKwonBK.Serum MicroRNAs reflect injury severity in a large animal model of thoracic spinal cord injury. Sci Rep2017;
7:1376
17.
TigchelaarSGuptaRShannonCPStreijgerFSinhaSFlibotteSRizzutoMAStreetJPaquetteSAilonTCharest-MorinRDeaNFisherCDvorakMFDhallSMac-ThiongJMParentSBaileyCChristieSVan Keuren-JensenKNislowCKwonBK.MicroRNA biomarkers in cerebrospinal fluid and serum reflect injury severity in human acute traumatic spinal cord injury. J Neurotrauma2019;
36:2358–71
ChuoSTChienJCLaiCP.Imaging extracellular vesicles: current and emerging methods. J Biomed Sci2018;
25:91
20.
SorkHCorsoGKrjutskovKJohanssonHJNordinJZWiklanderOPBLeeYXFWestholmJOLehtioJWoodMJAMagerIEl AndaloussiS.Heterogeneity and interplay of the extracellular vesicle small RNA transcriptome and proteome. Sci Rep2018;
8:10813
GheinaniAHVogeliMBaumgartnerUVassellaEDraegerABurkhardFCMonastyrskayaK.Improved isolation strategies to increase the yield and purity of human urinary exosomes for biomarker discovery. Sci Rep2018;
8:3945
23.
ZeringerEBartaTLiMVlassovAV.Strategies for isolation of exosomes. Cold Spring Harb Protoc2015;
2015:319–23
24.
NagarajahS.Exosome secretion – more than simple waste disposal? Implications for physiology, diagnostics and therapeutics. J Circ Biomark2016;
5:7
25.
IsolaALChenS.Exosomes: the messengers of health and disease. Curr Neuropharmacol2017;
15:157–65
26.
JalalianSHRamezaniMJalalianSAAbnousKTaghdisiSM.Exosomes, new biomarkers in early cancer detection. Anal Biochem2019;
571:1–13
27.
ChanBDWongWYLeeMMChoWCYeeBKKwanYWTaiWC.Exosomes in inflammation and inflammatory disease. Proteomics2019;
19:e1800149
28.
BeiYYuPCretoiuDCretoiuSMXiaoJ.Exosomes-based biomarkers for the prognosis of cardiovascular diseases. Adv Exp Med Biol2017;
998:71–88
29.
RezaieJAjeziSAvciCBKarimipourMGeranmayehMHNourazarianASokulluERezabakhshARahbarghaziR.Exosomes and their application in biomedical field: difficulties and advantages. Mol Neurobiol2018;
55:3372–93
30.
RevenfeldALBaekRNielsenMHStensballeAVarmingKJorgensenM.Diagnostic and prognostic potential of extracellular vesicles in peripheral blood. Clin Ther2014;
36:830–46
31.
MartirosyanNLCarotenutoAPatelAAKalaniMYYagmurluKLemoleGMJr.PreulMCTheodoreN.The role of microRNA markers in the diagnosis, treatment, and outcome prediction of spinal cord injury. Front Surg2016;
3:56
32.
ChenJWuYDuanFXWangSNGuoXYDingSQZhouJHHuJGLuHZ.Effect of M2 macrophage adoptive transfer on transcriptome profile of injured spinal cords in rats. Exp Biol Med2019;
244:880–92
33.
LuHZXuLZouJWangYXMaZWXuXMLuPH.Effects of autoimmunity on recovery of function in adult rats following spinal cord injury. Brain Behav Immun2008;
22:1217–30
34.
ShiLLZhangNXieXMChenYJWangRShenLZhouJSHuJGLuHZ.Transcriptome profile of rat genes in injured spinal cord at different stages by RNA-sequencing. BMC Genomics2017;
18:173
35.
WangZGersteinMSnyderM.RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet2009;
10:57–63
36.
FriedlanderMRChenWAdamidiCMaaskolaJEinspanierRKnespelSRajewskyN.Discovering microRNAs from deep sequencing data using miRDeep. Nat Biotechnol2008;
26:407–15
37.
T HoenPAAriyurekYThygesenHHVreugdenhilEVossenRHde MenezesRXBoerJMvan OmmenGJden DunnenJT.Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms. Nucleic Acids Res2008;
36:e141
38.
GrantGRLiuJStoeckertCJJr.A practical false discovery rate approach to identifying patterns of differential expression in microarray data. Bioinformatics2005;
21:2684–90
39.
StoreyJDTibshiraniR.Statistical significance for genomewide studies. Proc Natl Acad Sci U S A2003;
100:9440–5
40.
BellEWatsonHLBaileySMurrayMJColemanN.A robust protocol to quantify circulating cancer biomarker MicroRNAs. Methods Mol Biol2017;
1580:265–79
41.
LivakKJSchmittgenTD.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods2001;
25:402–8
KrugerJRehmsmeierM.RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res2006;
34:W451–4
44.
KanehisaMArakiMGotoSHattoriMHirakawaMItohMKatayamaTKawashimaSOkudaSTokimatsuTYamanishiY.KEGG for linking genomes to life and the environment. Nucl Acids Res2008;
36:D480–4
45.
Huang daWShermanBTLempickiRA.Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc2009;
4:44–57
46.
DennisGJr.ShermanBTHosackDAYangJGaoWLaneHCLempickiRA.DAVID: database for annotation, visualization, and integrated discovery. Genome Biol2003;
4:P3
47.
LesackKNauglerC.An open-source software program for performing Bonferroni and related corrections for multiple comparisons. J Pathol Inform2011;
2:52
48.
RodriguesLFMoura-NetoVTclsES.Biomarkers in spinal cord injury: from prognosis to treatment. Mol Neurobiol2018;
55:6436–48
49.
LiuXZhanZXuLMaFLiDGuoZLiNCaoX.MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIalpha. J Immunol2010;
185:7244–51
50.
StokowyTGawelDWojtasB.Differences in miRNA and mRNA profile of papillary thyroid cancer variants. Int J Endocrinol2016;
2016:1427042
51.
HanYLiuMWangZHuangMXuNWuL.Serum MicroRNAs related with chemoradiotherapy resistance in Advanced-Stage cervical squamous cell carcinoma. Transl Oncol2017;
10:378–84
52.
MoyaLMeijerJSchubertSMatinFBatraJ.Assessment of miR-98-5p, miR-152-3p, miR-326 and miR-4289 expression as biomarker for prostate cancer diagnosis. Int J Mol Sci2019;
20:1154
53.
YouWZhangXJiMYuYChenCXiongYLiuYSunYTanCZhangHLiJChenWLiR.MiR-152-5p as a microRNA passenger strand special functions in human gastric cancer cells. Int J Biol Sci2018;
14:644–53
54.
OuyangXJiangXGuDZhangYKongSKJiangCXieW.Dysregulated serum MiRNA profile and promising biomarkers in dengue-infected patients. Int J Med Sci2016;
13:195–205
55.
RouxMPerretCFeigerlovaEMohand OumoussaBSaulnierPJProustCTregouetDAHadjadjS.Plasma levels of hsa-miR-152-3p are associated with diabetic nephropathy in patients with type 2 diabetes. Nephrol Dial Transplant2018;
33:2201–7
56.
LugliGCohenAMBennettDAShahRCFieldsCJHernandezAGSmalheiserNR.Plasma exosomal miRNAs in persons with and without alzheimer disease: altered expression and prospects for biomarkers. PLoS One2015;
10:e0139233
57.
WangYJiaoJZhangSZhengCWuM.RIP3 inhibition protects locomotion function through ameliorating mitochondrial antioxidative capacity after spinal cord injury. Biomed Pharmacother2019;
116:109019
58.
CiafreSAGalardiSMangiolaAFerracinMLiuCGSabatinoGNegriniMMairaGCroceCMFaraceMG.Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun2005;
334:1351–8
59.
GrecoSJRameshwarP.MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells. Proc Natl Acad Sci U S A2007;
104:15484–9
60.
ChenYGorskiDH.Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood2008;
111:1217–26
61.
XiaoFYuJLiuBGuoYLiKDengJZhangJWangCChenSDuYLuYXiaoYZhangZGuoF.A novel function of microRNA 130a-3p in hepatic insulin sensitivity and liver steatosis. Diabetes2014;
63:2631–42
62.
LiuYLiYWangRQinSLiuJSuFYangYZhaoFWangZWuQ.MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells. J Exp Clin Cancer Res2016;
35:19
63.
WangSHanHHuYYangWLvYWangLZhangLJiJ.MicroRNA-130a-3p suppresses cell migration and invasion by inhibition of TBL1XR1-mediated EMT in human gastric carcinoma. Mol Carcinog2018;
57:383–92
64.
QuRSunYLiYHuCShiGTangYGuoD.MicroRNA-130a-3p suppresses cell viability, proliferation and invasion in nasopharyngeal carcinoma by inhibiting CXCL12. Am J Transl Res2017;
9:3586–98
65.
HuBZhangHWangZZhangFWeiHLiL.LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4. Cancer Biol Ther2017;
18:974–83
66.
AsukaiKKawamotoKEguchiHKonnoMAsaiAIwagamiYYamadaDAsaokaTNodaTWadaHGotohKNishidaNSatohTDokiYMoriMIshiiH.Micro-RNA-130a-3p regulates gemcitabine resistance via PPARG in cholangiocarcinoma. Ann Surg Oncol2017;
24:2344–52
67.
WangYDuJNiuXFuNWangRZhangYZhaoSSunDNanY.MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2. Cell Death Dis2017;
8:e2792
68.
ZhuZWangDJiaoWChenGCaoYZhangQWangJ.Bioinformatics analyses of pathways and gene predictions in IL-1alpha and IL-1beta knockout mice with spinal cord injury. Acta Histochem2017;
119:663–70
69.
van RooijESutherlandLBLiuNWilliamsAHMcAnallyJGerardRDRichardsonJAOlsonEN.A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A2006;
103:18255–60
70.
LanevePDi MarcotullioLGioiaUFioriMEFerrettiEGulinoABozzoniICaffarelliE.The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. Proc Natl Acad Sci U S A2007;
104:7957–62
71.
SonkolyEWeiTJansonPCSaafALundebergLTengvall-LinderMNorstedtGAleniusHHomeyBScheyniusAStahleMPivarcsiA.MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?.PLoS One2007;
2:e610
72.
LeMTTehCShyh-ChangNXieHZhouBKorzhVLodishHFLimB.MicroRNA-125b is a novel negative regulator of p53. Genes Dev2009;
23:862–76
73.
BeattieMSFarooquiAABresnahanJC.Review of current evidence for apoptosis after spinal cord injury. J Neurotrauma2000;
17:915–25
74.
PinchiEFratiACantatoreSD'ErricoSRussaRMaieseAPalmieriMPesceAViolaRVFratiPFineschiV.Acute spinal cord injury: a systematic review investigating miRNA families involved. Int J Mol Sci2019;
20:1841
75.
WangYYuanYGaoYLiXTianFLiuFDuRLiPWangFXuSWuXWangC.MicroRNA-31 regulating apoptosis by mediating the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in treatment of spinal cord injury.Brain Dev2019;
41:649–61
76.
LiFZhouMW.MicroRNAs in contusion spinal cord injury: pathophysiology and clinical utility. Acta Neurol Belg2019;
119:21–7
77.
WangE.MicroRNA, the putative molecular control for mid-life decline. Ageing Res Rev2007;
6:1–11
78.
BarnesMRDeharoSGrocockRJBrownJRSanseauP.The micro RNA target paradigm: a fundamental and polymorphic control layer of cellular expression. Expert Opin Biol Ther2007;
7:1387–99
79.
IchimuraARuikeYTerasawaKTsujimotoG.miRNAs and regulation of cell signaling. Febs J2011;
278:1610–8
80.
HollisER2nd.Axon guidance molecules and neural circuit remodeling after spinal cord injury. Neurotherapeutics2016;
13:360–9
81.
OnishiKHollisEZouY.Axon guidance and injury-lessons from Wnts and Wnt signaling. Curr Opin Neurobiol2014;
27:232–40
82.
ClarkCELiuYCooperHM.The yin and yang of wnt/ryk axon guidance in development and regeneration. Sci China Life Sci2014;
57:366–71
83.
GarciaALUdehAKalahastyKHackamAS.A growing field: the regulation of axonal regeneration by Wnt signaling. Neural Regen Res2018;
13:43–52
84.
LambertCCisternasPInestrosaNC.Role of Wnt signaling in Central nervous system injury. Mol Neurobiol2016;
53:2297–311
85.
FarooquiAAHorrocksLA.Involvement of glutamate receptors, lipases, and phospholipases in long-term potentiation and neurodegeneration. J Neurosci Res1994;
38:6–11
86.
ChenRCohenLGHallettM.Nervous system reorganization following injury. Neuroscience2002;
111:761–73
87.
ZhouJXiongQChenHYangCFanY.Identification of the spinal expression profile of non-coding RNAs involved in neuropathic pain following spared nerve injury by sequence analysis. Front Mol Neurosci2017;
10:91
88.
GrahamZAQinWHarlowLCRossNHBaumanWAGallagherPMCardozoCP.Focal adhesion kinase signaling is decreased 56 days following spinal cord injury in rat gastrocnemius. Spinal Cord2016;
54:502–9
89.
HaoMJiXRChenHZhangWZhangLCZhangLHTangPFLuN.Cell cycle and complement inhibitors may be specific for treatment of spinal cord injury in aged and young mice: transcriptomic analyses. Neural Regen Res2018;
13:518–27
90.
ChuangYCLeeCHSunWHChenCC.Involvement of advillin in somatosensory neuron subtype-specific axon regeneration and neuropathic pain. Proc Natl Acad Sci U S A2018;
115:E8557–E66
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
